An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.

Autor: Quiroga, Dionisia, Wesolowski, Robert, Zelinskas, Sara, Pinette, Ashley, Benner, Brooke, Schwarz, Emily, Savardekar, Himanshu, Johnson, Courtney, Stiff, Andrew, Yu, Lianbo, Macrae, Erin, Lustberg, Maryam, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Carson III, William E.
Zdroj: Cancer Control: Journal of the Moffitt Cancer Center; 5/26/2024, p1-15, 15p
Databáze: Complementary Index